Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 40.37% is in line with its 5-year average of 39.82%, around the middle of its 5-year range (36.31%–49.77%).
1.45% above its 12-month average of 39.79%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
40.37%
GROSS MARGIN AVG TTM
39.79%
GROSS MARGIN AVG 3Y
40.25%
GROSS MARGIN AVG 5Y
39.82%
GROSS MARGIN AVG 10Y
43.47%
GROSS MARGIN AVG 15Y
44.02%
GROSS MARGIN AVG 20Y
43.23%
CURRENT VS TTM AVG
+1.45%
CURRENT VS 3Y AVG
+0.30%
CURRENT VS 5Y AVG
+1.38%
CURRENT VS 10Y AVG
-7.12%
CURRENT VS 15Y AVG
-8.30%
CURRENT VS 20Y AVG
-6.61%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-31.57%
vs the sector median at left
Thermo Fisher Scientific Inc.
Market Cap
$224.89B
Gross Margin
40.37%
TTM Avg
39.79%
3Y Avg
40.25%
5Y Avg
39.82%
Market Cap
$182.97B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$181.18B
Gross Margin
79.59%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$143.87B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$132.33B
Gross Margin
86.04%
TTM Avg
85.57%
3Y Avg
86.56%
5Y Avg
87.08%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $224.89B | 40.37% | 39.79% | 40.25% | 39.82% |
| Amgen Inc. (AMGN)vs › | $210.62B | 72.65% | 66.16% | 69.53% | 71.51% |
| AstraZeneca PLC (AZN)vs › | $244.62B | 81.88% | 81.51% | 79.26% | 77.31% |
| Novo Nordisk A/S (NVO)vs › | $198.74B | 80.64% | 82.83% | 83.54% | 83.48% |
| Abbott Laboratories (ABT)vs › | $182.97B | 56.80% | 53.17% | 51.86% | 51.92% |
| Gilead Sciences, Inc. (GILD)vs › | $181.18B | 79.59% | 78.55% | 78.10% | 78.28% |
| Pfizer Inc. (PFE)vs › | $158.99B | 71.32% | 68.05% | 62.23% | 63.06% |
| Danaher Corporation (DHR)vs › | $143.87B | 58.51% | 60.22% | 59.98% | 59.48% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.33B | 86.04% | 85.57% | 86.56% | 87.08% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.71B | 70.16% | 63.94% | 60.40% | 58.39% |
Gross Margin
40.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-27 | 41.21% |
| 2026-03-28 | 40.67% |
| 2025-12-31 | 37.95% |
| 2025-09-27 | 41.83% |
| 2025-06-28 | 37.29% |
| 2025-03-29 | 40.96% |
| 2024-12-31 | 39.20% |
| 2024-09-28 | 40.98% |
| 2024-06-29 | 41.21% |
| 2024-03-30 | 40.76% |
| 2023-12-31 | 36.31% |
| 2023-09-30 | 40.97% |
| 2023-07-01 | 39.95% |
| 2023-04-01 | 39.07% |
| 2022-12-31 | 36.31% |
| 2022-10-01 | 40.47% |
| 2022-07-02 | 41.80% |
| 2022-04-02 | 46.40% |
| 2021-12-31 | 46.07% |
| 2021-10-02 | 49.77% |
| 2021-07-03 | 48.91% |
| 2021-04-03 | 52.54% |
| 2020-12-31 | 50.12% |
| 2020-09-26 | 50.86% |
| 2020-06-27 | 48.85% |
| 2020-03-28 | 43.96% |
| 2019-12-31 | 39.99% |
| 2019-09-28 | 44.12% |
| 2019-06-29 | 44.82% |
| 2019-03-30 | 44.26% |
| 2018-12-31 | 40.36% |
| 2018-09-29 | 44.17% |
| 2018-06-30 | 45.10% |
| 2018-03-31 | 44.17% |
| 2017-12-31 | 39.72% |
| 2017-09-30 | 45.91% |
| 2017-07-01 | 45.77% |
| 2017-04-01 | 46.69% |
| 2016-12-31 | 47.32% |
| 2016-10-01 | 47.06% |
| 2016-07-02 | 48.20% |
| 2016-04-02 | 47.94% |
| 2015-12-31 | 47.56% |
| 2015-09-26 | 48.29% |
| 2015-06-27 | 47.97% |
| 2015-03-28 | 49.25% |
| 2014-12-31 | 46.56% |
| 2014-09-27 | 49.01% |
| 2014-06-28 | 45.37% |
| 2014-03-29 | 43.85% |
| 2013-12-31 | 44.30% |
| 2013-09-28 | 43.98% |
| 2013-06-29 | 43.80% |
| 2013-03-30 | 43.63% |
| 2012-12-31 | 42.53% |
| 2012-09-29 | 43.86% |
| 2012-06-30 | 44.24% |
| 2012-03-31 | 43.45% |
| 2011-12-31 | 43.33% |
| 2011-10-01 | 42.75% |
| 2011-07-02 | 41.62% |
| 2011-04-02 | 42.39% |
| 2010-12-31 | 41.78% |
| 2010-10-02 | 42.15% |
| 2010-07-03 | 42.12% |
| 2010-04-03 | 42.25% |
| 2009-12-31 | 40.09% |
| 2009-09-26 | 41.16% |
| 2009-06-27 | 41.00% |
| 2009-03-31 | 39.33% |
| 2008-12-31 | 40.32% |
| 2008-09-27 | 39.91% |
| 2008-06-28 | 40.16% |
| 2008-03-29 | 39.87% |
| 2007-12-31 | 39.67% |
| 2007-09-29 | 39.48% |
| 2007-06-30 | 39.26% |
| 2007-03-31 | 37.63% |
| 2006-12-31 | 35.60% |
| 2006-09-30 | 46.47% |
| 2006-07-01 | 45.48% |
| 2006-04-01 | 45.69% |
| 2005-12-31 | 46.24% |
| 2005-10-01 | 44.99% |
| 2005-07-02 | 43.98% |
| 2005-04-02 | 46.36% |
| 2004-12-31 | 46.27% |
| 2004-10-02 | 46.27% |
| 2004-07-03 | 45.48% |
| 2004-04-03 | 45.46% |
| 2003-12-31 | 45.44% |
| 2003-09-27 | 45.44% |
| 2003-06-28 | 45.15% |
| 2003-03-29 | 44.75% |
| 2002-12-31 | 43.13% |
| 2002-09-28 | 44.21% |
